Summary

Recent studies indicate that primary aldosteronism (PA) is a much more common cause of hypertension than had been demonstrated historically. In patients with resistant hypertension, the prevalence of PA from different clinics worldwide is about 10-20%. As has been no such data in China, the investigators are conducting a PA study in different provinces of China to evaluate the prevalence of PA in patients with resistant hypertension.

Study Name: Primary Aldosteronism In Hypertensive Patients in China
Status: Completed
Conditions: Primary aldosteronism, Hypertension
Interventions: Observational only
Locations: The First Affiliated Hospital of Chongqing Medical University, Chongqing, Chongqing, China
Study link: https://ClinicalTrials.gov/show/NCT03155139

To search for other studies by topic, location, or status, go to our Clinical Studies page.

©2021 Primary Aldosteronism Foundation — All Rights Reserved

The Primary Aldosteronism Foundation is a registered 501(c)(3) public charity. Donations are tax deductible in the US.

©2021 Primary Aldosteronism Foundation

The Primary Aldosteronism Foundation is a registered 501(c)(3) public charity. Donations are tax deductible in the US.